Metraipolis › archive › dc_87bb5e9957bf

Efficacy and prognostic factors of first-line bevacizumab plus chemotherapy in elderly patients with advanced driver gene-negative lung adenocarcinoma: A… — Europe PMC PMID:42499069

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42499069
DOI
10.1097/md.0000000000049939
License (as archived)
solo-consultazione
Archived
2026-10-18T12:17:44.176Z
SHA-256 of the archived text
6d88135495d794d875dc64d5b7bee7b4f0eb14cceb565509c6e45021246bea3b
Stable URL of this page
https://metraipolis.com/documento/dc_87bb5e9957bf

How to cite

Efficacy and prognostic factors of first-line bevacizumab plus chemotherapy in elderly patients with advanced driver gene-negative lung adenocarcinoma: A… — Europe PMC PMID:42499069 — Europe PMC (en), https://europepmc.org/article/MED/42499069 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_87bb5e9957bf (Metraipolis archive dc_87bb5e9957bf, sha256 6d88135495d794d875dc64d5b7bee7b4f0eb14cceb565509c6e45021246bea3b)
BibTeX
@misc{dc87bb5e9957bf,
  title = {Efficacy and prognostic factors of first-line bevacizumab plus chemotherapy in elderly patients with advanced driver gene-negative lung adenocarcinoma: A… — Europe PMC PMID:42499069},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42499069},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_87bb5e9957bf; sha256 6d88135495d794d875dc64d5b7bee7b4f0eb14cceb565509c6e45021246bea3b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42499069. Agents can read the archived copy with the MCP tool read_document.